VALEANT PHARMACEUTICALS INTL
COM · CUSIP 91911K102
1
institutional holders
-1 vs Q1 2022
1.4m
shares reported held*
$11.5mreported value*
0 new
0 added
0 reduced
1 sold out
net sold ≈ $103.4k (-12.4k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $8.35.
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 2 |
| Q1 2020 | 3 |
| Q2 2020 | 3 |
| Q3 2020 | 3 |
| Q4 2020 | 3 |
| Q1 2021 | 3 |
| Q2 2021 | 3 |
| Q3 2021 | 2 |
| Q4 2021 | 2 |
| Q1 2022 | 2 |
| Q2 2022 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2020 | 1 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 1 |
| Q3 2021 | 0 | 2 |
| Q4 2021 | 0 | 0 |
| Q1 2022 | 0 | 1 |
| Q2 2022 | 0 | 1 |
Biggest buyers
| None |
Biggest sellers
| LeJeune Puetz Investment Counsel LLC | Sold out | -12.4k |
Holders, Q2 2022
| Manager | Shares | Change |
|---|---|---|
| Bruce & Co., Inc. 2.71% of their portfolio | 1.4m $11.5m | Unchanged |